Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Juan I, Patrucco, Liliana, Cristiano, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337150/
https://www.ncbi.nlm.nih.gov/pubmed/32669904
http://dx.doi.org/10.2147/DNND.S46557
_version_ 1783554453142503424
author Rojas, Juan I
Patrucco, Liliana
Cristiano, Edgardo
author_facet Rojas, Juan I
Patrucco, Liliana
Cristiano, Edgardo
author_sort Rojas, Juan I
collection PubMed
description Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000–8,000 patients, with nearly 55%–65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.
format Online
Article
Text
id pubmed-7337150
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73371502020-07-14 Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review Rojas, Juan I Patrucco, Liliana Cristiano, Edgardo Degener Neurol Neuromuscul Dis Review Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000–8,000 patients, with nearly 55%–65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS. Dove 2014-06-20 /pmc/articles/PMC7337150/ /pubmed/32669904 http://dx.doi.org/10.2147/DNND.S46557 Text en © 2014 Rojas et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
spellingShingle Review
Rojas, Juan I
Patrucco, Liliana
Cristiano, Edgardo
Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title_full Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title_fullStr Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title_full_unstemmed Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title_short Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
title_sort current and emerging treatments for relapsing multiple sclerosis in argentinian patients: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337150/
https://www.ncbi.nlm.nih.gov/pubmed/32669904
http://dx.doi.org/10.2147/DNND.S46557
work_keys_str_mv AT rojasjuani currentandemergingtreatmentsforrelapsingmultiplesclerosisinargentinianpatientsareview
AT patruccoliliana currentandemergingtreatmentsforrelapsingmultiplesclerosisinargentinianpatientsareview
AT cristianoedgardo currentandemergingtreatmentsforrelapsingmultiplesclerosisinargentinianpatientsareview

Ejemplares similares